RADIATION SAFETY CONSIDERATIONS FOR THE USE OF (223)RaCl(2) DE IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER

The majority of patients with late stage castration-resistant prostate cancer (CRPC) develop bone metastases that often result in significant bone pain. Therapeutic palliation strategies can delay or prevent skeletal complications and may prolong survival. An alpha-particle based therapy, radium-223...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Health Phys
Main Authors: Dauer, Lawrence T., Williamson, Matthew J., Humm, John, O’Donoghue, Joseph, Ghani, Rashid, Awadallah, Robert, Carrasquillo, Jorge, Pandit-Taskar, Neeta, Aksnes, Anne-Kirsti, Biggin, Colin, Reinton, Vigdis, Morris, Michael, St Germain, Jean
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4981573/
https://ncbi.nlm.nih.gov/pubmed/24562070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HP.0b013e3182a82b37
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares